Fabian Hansen is the founder and Managing Director of U.S. venture capital fund Presight Capital, which invests $600m into global biotech, healthtech, fintech, and deeptech ventures. A graduate of The London School of Economics (LSE), Fabian has been working in venture capital since 2013. Over the years, Fabian was an early investor in numerous category-defining companies including AbCellera, Razor group, Valoreo, Rario, Velocity, Syfe, Peptilogics, ATAI, Compass Pathways and AngieX. Fabian serves on the board of Alloy, Valoreo, Peptilogics and Angiex.Born and raised in Germany, Fabian is fluent in German, English and Italian and holds dual citizenship. In 2020, he was featured in Forbes’ “30 under 30” list in the Finance category.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Alloy Therapeutics | Director | Feb 1, 2021 | — | Detail |